LVS vs TRDA · P/E 28, rev $6.74B vs P/E 12, rev $1.8M
Las Vegas Sands Corp (LVS) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Latest reported TRDA revenue for 2026-06-30 was $1.8M. Net income was -$82.5M. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
LVS currently screens at market cap $35.70B and trailing P/E 28.3. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the LVS and TRDA stock pages for the full models.
Not investment advice.